<p>Moderna Inc said on Friday it aims to deliver one billion doses of its Covid-19 vaccine to low-income countries in 2022, in addition to the doses it has already committed to the global vaccine-sharing platform COVAX.</p>.<p>These vaccines will be part of the 2-3 billion doses the company had forecast to produce next year.</p>.<p>"To date, more than 250 million people have been vaccinated globally with the Moderna Covid-19 vaccine. However, we recognize that access to vaccines continues to be a challenge in many parts of the world," Chief Executive Officer Stéphane Bancel said in a letter posted on the company's website.</p>.<p><a href="http://www.deccanherald.com/tag/covid-19"><strong>SPECIAL CORONAVIRUS COVERAGE ONLY ON DH</strong></a></p>.<p>Moderna on Thursday announced plans to invest up to $500 million to build a factory in Africa to make up to 500 million doses of mRNA vaccines each year, including its Covid-19 shot.</p>.<p>The company had committed in May to supply up to 500 million doses of its Covid-19 vaccine to the COVAX facility from the fourth quarter of 2021 through 2022.</p>.<p>"We are committed to doubling our manufacturing and expanding supply even further until our vaccine is no longer needed in low-income countries," Bancel said.</p>.<p><strong>Check out DH's latest videos:</strong></p>
<p>Moderna Inc said on Friday it aims to deliver one billion doses of its Covid-19 vaccine to low-income countries in 2022, in addition to the doses it has already committed to the global vaccine-sharing platform COVAX.</p>.<p>These vaccines will be part of the 2-3 billion doses the company had forecast to produce next year.</p>.<p>"To date, more than 250 million people have been vaccinated globally with the Moderna Covid-19 vaccine. However, we recognize that access to vaccines continues to be a challenge in many parts of the world," Chief Executive Officer Stéphane Bancel said in a letter posted on the company's website.</p>.<p><a href="http://www.deccanherald.com/tag/covid-19"><strong>SPECIAL CORONAVIRUS COVERAGE ONLY ON DH</strong></a></p>.<p>Moderna on Thursday announced plans to invest up to $500 million to build a factory in Africa to make up to 500 million doses of mRNA vaccines each year, including its Covid-19 shot.</p>.<p>The company had committed in May to supply up to 500 million doses of its Covid-19 vaccine to the COVAX facility from the fourth quarter of 2021 through 2022.</p>.<p>"We are committed to doubling our manufacturing and expanding supply even further until our vaccine is no longer needed in low-income countries," Bancel said.</p>.<p><strong>Check out DH's latest videos:</strong></p>